Non-opioid Pain Patches Market Report

Non-opioid Pain Patches Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Dec 28, 2019
  • PAGES：174
  • REPORT CODE：GMM415512
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Non-opioid Pain Patches market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.2% during the forecast period.

    This report presents the market size and development trends by detailing the Non-opioid Pain Patches market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Non-opioid Pain Patches market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Non-opioid Pain Patches industry and will help you to build a panoramic view of the industrial development.

    Non-opioid Pain Patches Market, By Type:

    • Lidocaine Patch

    • Diclofenac Patch

    • Methyl Salicylate Patch

    • Capsaicin Patch

    • Ketoprofen Patch

    • Other

    Non-opioid Pain Patches Market, By Application:

    • Hospital Pharmacies

    • Independent Pharmacies & Drug Stores

    • Online Pharmacies

    Some of the leading players are as follows:

    • GlaxoSmithKline

    • Allergan PLC

    • Novartis AG

    • Pfizer

    • Hisamitsu Pharmaceutical

    • Endo International

    • IBSA Institut Biochimque SA

    • Acorda Therapeutics

    • TEH SENG Pharmaceutical

    • Teva Pharmaceutical Industries

    • Teikoku Seiyaku

    • Johnson & Johnson

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Non-opioid Pain Patches Market: Technology Type Analysis

    • 4.1 Non-opioid Pain Patches Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Non-opioid Pain Patches Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Lidocaine Patch

      • 4.3.2 Diclofenac Patch

      • 4.3.3 Methyl Salicylate Patch

      • 4.3.4 Capsaicin Patch

      • 4.3.5 Ketoprofen Patch

      • 4.3.6 Other

    5 Non-opioid Pain Patches Market: Product Analysis

    • 5.1 Non-opioid Pain Patches Product Market Share Analysis, 2018 & 2026

    • 5.2 Non-opioid Pain Patches Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Non-opioid Pain Patches Market: Application Analysis

    • 6.1 Non-opioid Pain Patches Application Market Share Analysis, 2018 & 2026

    • 6.2 Non-opioid Pain Patches Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital Pharmacies

      • 6.3.2 Independent Pharmacies & Drug Stores

      • 6.3.3 Online Pharmacies

    7 Non-opioid Pain Patches Market: Regional Analysis

    • 7.1 Non-opioid Pain Patches Regional Market Share Analysis, 2018 & 2026

    • 7.2 Non-opioid Pain Patches Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 GlaxoSmithKline

      • 9.1.1 GlaxoSmithKline Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Allergan PLC

      • 9.2.1 Allergan PLC Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Novartis AG

      • 9.3.1 Novartis AG Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Pfizer

      • 9.4.1 Pfizer Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Hisamitsu Pharmaceutical

      • 9.5.1 Hisamitsu Pharmaceutical Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Endo International

      • 9.6.1 Endo International Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 IBSA Institut Biochimque SA

      • 9.7.1 IBSA Institut Biochimque SA Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Acorda Therapeutics

      • 9.8.1 Acorda Therapeutics Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 TEH SENG Pharmaceutical

      • 9.9.1 TEH SENG Pharmaceutical Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Teva Pharmaceutical Industries

      • 9.10.1 Teva Pharmaceutical Industries Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Teikoku Seiyaku

      • 9.11.1 Teikoku Seiyaku Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Johnson & Johnson

      • 9.12.1 Johnson & Johnson Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

     

    The List of Tables and Figures (Totals 104 Figures and 145 Tables)

    • Figure Lidocaine Patch Non-opioid Pain Patches market, 2015 - 2026 (USD Million)

    • Figure Diclofenac Patch Non-opioid Pain Patches market, 2015 - 2026 (USD Million)

    • Figure Methyl Salicylate Patch Non-opioid Pain Patches market, 2015 - 2026 (USD Million)

    • Figure Capsaicin Patch Non-opioid Pain Patches market, 2015 - 2026 (USD Million)

    • Figure Ketoprofen Patch Non-opioid Pain Patches market, 2015 - 2026 (USD Million)

    • Figure Other Non-opioid Pain Patches market, 2015 - 2026 (USD Million)

    • Figure Hospital Pharmacies market, 2015 - 2026 (USD Million)

    • Figure Independent Pharmacies & Drug Stores market, 2015 - 2026 (USD Million)

    • Figure Online Pharmacies market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Non-opioid Pain Patches market, by country, 2015 - 2026 (USD Million)

    • Table North America Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table North America Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table North America Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Canada Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Canada Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Europe Non-opioid Pain Patches market, by country, 2015 - 2026 (USD Million)

    • Table Europe Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Europe Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Europe Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Germany Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Germany Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table France Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table France Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Italy Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Italy Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Spain Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Spain Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Non-opioid Pain Patches market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table China Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table China Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Japan Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Japan Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table India Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table India Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Non-opioid Pain Patches market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table MEA Non-opioid Pain Patches market, by country, 2015 - 2026 (USD Million)

    • Table MEA Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table MEA Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table MEA Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Non-opioid Pain Patches market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Non-opioid Pain Patches market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Non-opioid Pain Patches market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Allergan PLC Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Hisamitsu Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Endo International Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table IBSA Institut Biochimque SA Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Acorda Therapeutics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table TEH SENG Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Teva Pharmaceutical Industries Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Teikoku Seiyaku Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US